Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 204

    1.

    Expression of POU-domain transcription factor, Oct-6, in schizophrenia, bipolar disorder and major depression.

    Ubhi K, Price J.

    BMC Psychiatry. 2005 Oct 24;5:38.PMID: 16246257 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Hippocampal FGF-2 and FGFR1 mRNA expression in major depression, schizophrenia and bipolar disorder.

    Gaughran F, Payne J, Sedgwick PM, Cotter D, Berry M.

    Brain Res Bull. 2006 Jul 31;70(3):221-7. Epub 2006 May 12.PMID: 16861106 [PubMed - indexed for MEDLINE]Related articles

    4.

    Expression of Oct-6, a POU III domain transcription factor, in schizophrenia.

    Ilia M, Beasley C, Meijer D, Kerwin R, Cotter D, Everall I, Price J.

    Am J Psychiatry. 2002 Jul;159(7):1174-82. Retraction in: Beasley C, Meijer D, Kerwin R, Cotter D, Everall I, Price J. Am J Psychiatry. 2006 Aug;163(8):1454. PMID: 12091196 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    MRNA expression patterns and distribution of white matter neurons in dorsolateral prefrontal cortex of depressed patients differ from those in schizophrenia patients.

    Molnar M, Potkin SG, Bunney WE, Jones EG.

    Biol Psychiatry. 2003 Jan 1;53(1):39-47.PMID: 12513943 [PubMed - indexed for MEDLINE]Related articles

    6.

    Decreased expression of mineralocorticoid receptor mRNA in the prefrontal cortex in schizophrenia and bipolar disorder.

    Xing GQ, Russell S, Webster MJ, Post RM.

    Int J Neuropsychopharmacol. 2004 Jun;7(2):143-53. Epub 2004 Jan 23.PMID: 14741058 [PubMed - indexed for MEDLINE]Related articles

    8.

    Subcortical oligodendrocyte- and astrocyte-associated gene expression in subjects with schizophrenia, major depression and bipolar disorder.

    Barley K, Dracheva S, Byne W.

    Schizophr Res. 2009 Jul;112(1-3):54-64. Epub 2009 May 17.PMID: 19447584 [PubMed - indexed for MEDLINE]Related articles

    9.

    Striatal ionotropic glutamate receptor expression in schizophrenia, bipolar disorder, and major depressive disorder.

    Meador-Woodruff JH, Hogg AJ Jr, Smith RE.

    Brain Res Bull. 2001 Jul 15;55(5):631-40.PMID: 11576760 [PubMed - indexed for MEDLINE]Related articles

    10.

    Serotonin 5-HT1A, 5-HT1B, and 5-HT2A receptor mRNA expression in subjects with major depression, bipolar disorder, and schizophrenia.

    López-Figueroa AL, Norton CS, López-Figueroa MO, Armellini-Dodel D, Burke S, Akil H, López JF, Watson SJ.

    Biol Psychiatry. 2004 Feb 1;55(3):225-33. Erratum in: Biol Psychiatry. 2004 Mar 15;55(6):660. PMID: 14744462 [PubMed - indexed for MEDLINE]Related articles

    11.

    Differential hippocampal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia.

    Heckers S, Stone D, Walsh J, Shick J, Koul P, Benes FM.

    Arch Gen Psychiatry. 2002 Jun;59(6):521-9.PMID: 12044194 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Hippocampal synaptic pathology in schizophrenia, bipolar disorder and major depression: a study of complexin mRNAs.

    Eastwood SL, Harrison PJ.

    Mol Psychiatry. 2000 Jul;5(4):425-32.PMID: 10889554 [PubMed - indexed for MEDLINE]Related articles

    13.

    Reduction in Reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression.

    Fatemi SH, Earle JA, McMenomy T.

    Mol Psychiatry. 2000 Nov;5(6):654-63, 571.PMID: 11126396 [PubMed - indexed for MEDLINE]Related articles

    14.

    Striatal excitatory amino acid transporter transcript expression in schizophrenia, bipolar disorder, and major depressive disorder.

    McCullumsmith RE, Meador-Woodruff JH.

    Neuropsychopharmacology. 2002 Mar;26(3):368-75.PMID: 11850151 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Differences in the cellular distribution of D1 receptor mRNA in the hippocampus of bipolars and schizophrenics.

    Pantazopoulos H, Stone D, Walsh J, Benes FM.

    Synapse. 2004 Dec 1;54(3):147-55.PMID: 15452863 [PubMed - indexed for MEDLINE]Related articles

    16.

    Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains.

    Torrey EF, Barci BM, Webster MJ, Bartko JJ, Meador-Woodruff JH, Knable MB.

    Biol Psychiatry. 2005 Feb 1;57(3):252-60.PMID: 15691526 [PubMed - indexed for MEDLINE]Related articles

    17.

    Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders.

    Webster MJ, Knable MB, O'Grady J, Orthmann J, Weickert CS.

    Mol Psychiatry. 2002;7(9):985-94, 924.PMID: 12399952 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Changes in region- and cell type-specific expression patterns of neutral amino acid transporter 1 (ASCT-1) in the anterior cingulate cortex and hippocampus in schizophrenia, bipolar disorder and major depression.

    Weis S, Llenos IC, Dulay JR, Verma N, Sabunciyan S, Yolken RH.

    J Neural Transm. 2007 Feb;114(2):261-71. Epub 2006 Aug 10.PMID: 16897601 [PubMed - indexed for MEDLINE]Related articles

    19.

    Alterations in cell adhesion molecule L1 and functionally related genes in major depression: a postmortem study.

    Laifenfeld D, Karry R, Klein E, Ben-Shachar D.

    Biol Psychiatry. 2005 Apr 1;57(7):716-25.PMID: 15820228 [PubMed - indexed for MEDLINE]Related articles

    20.

    Reduction of dopamine-related transcription factors Nurr1 and NGFI-B in the prefrontal cortex in schizophrenia and bipolar disorders.

    Xing G, Zhang L, Russell S, Post R.

    Schizophr Res. 2006 May;84(1):36-56. Epub 2006 May 2.PMID: 16631355 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination